ONE-YEAR SAFETY AND EFFICACY OF INTRAVITREAL TRIAMCINOLONE ACETONIDE FOR THE MANAGEMENT OF MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION
暂无分享,去创建一个
P. Rosenfeld | H. Flynn | C. Puliafito | I. Scott | G. Gregori | A. Berrocal | N. Gregori | T. Murray | W. Smiddy | J. E. Lee | E. Mavrofrides | Giovanni Gregori
[1] L. D. Del Priore,et al. INTRAVITREAL TRIAMCINOLONE TREATMENT FOR MACULAR EDEMA ASSOCIATED WITH CENTRAL RETINAL VEIN OCCLUSION AND HEMIRETINAL VEIN OCCLUSION , 2005, Retina.
[2] P. Rosenfeld,et al. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. , 2005, Ophthalmology.
[3] T. Williamson,et al. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion. , 2005, American journal of ophthalmology.
[4] S. Sacu,et al. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion. , 2005, Acta ophthalmologica Scandinavica.
[5] J. Jonas,et al. Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. , 2003, American journal of ophthalmology.
[6] P. Campochiaro,et al. VEGF‐TRAPR1R2 suppresses choroidal neovascularization and VEGF‐induced breakdown of the blood–retinal barrier , 2003 .
[7] M. Ip,et al. Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study , 2003, Seminars in ophthalmology.
[8] S. Fekrat,et al. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. , 2004, American journal of ophthalmology.
[9] J. Lim,et al. Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion , 2022 .
[10] M. Ip,et al. Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion. , 2002, Archives of ophthalmology.
[11] J. Jonas,et al. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion , 2002, Graefe’s Archive for Clinical and Experimental Ophthalmology.
[12] J. Duker,et al. Intravitreal triamcinolone for refractory diabetic macular edema. , 2002, Ophthalmology.
[13] J. Duker,et al. Dramatic regression of conjunctival and corneal acquired melanosis with topical mitomycin C , 2002, The British journal of ophthalmology.
[14] E. Opremcak,et al. RADIAL OPTIC NEUROTOMY FOR CENTRAL RETINAL VEIN OCCLUSION: A Retrospective Pilot Study of 11 Consecutive Cases , 2001, Retina.
[15] J. Marshall,et al. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. , 2001, Ophthalmology.
[16] G. Soubrane,et al. Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study , 2000, British Journal of Ophthalmology.
[17] G. Karakiulakis,et al. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. , 1998, European journal of pharmacology.
[18] H. Wieland,et al. Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids. , 1997, American journal of respiratory cell and molecular biology.
[19] David J. Wilson,et al. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report. , 1995, Ophthalmology.
[20] I. Constable,et al. Laser-induced chorioretinal venous anastomosis for treatment of nonischemic central retinal vein occlusion. , 1995, Archives of ophthalmology.
[21] Ditte J. Hess,et al. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report. , 1995, Ophthalmology.